FDA greenlights Jardiance for treating chronic kidney disease

FDA greenlights Jardiance for treating chronic kidney disease

Source: 
Medical Marketing and Media
snippet: 

The approval comes weeks after the Biden administration announced Jardiance was among the first 10 prescription drugs selected for Medicare price negotiations under the Inflation Reduction Act.